Common Contracts
1 similar Global Licensing Agreement contracts
ContractGlobal Licensing Agreement • October 25th, 2011
Tokyo, Japan, October 20, 2011: Oncolys BioPharma Inc., Bristol-Myers Squibb Company (NYSE:BMY) and Yale University have received a 2011 Deals of DistinctionTM Award from the Licensing Executives Society (U.S.A. and Canada) in recognition of an agreement for the development of an investigational HIV compound. The compound is now known as BMS-986001/OBP-601, a once-a-day, orally available nucleoside reverse transcriptase inhibitor (NRTI) in Phase II development. The transaction was selected as winner of the Industry-University-Government Interface (IUGI) category of the Deals of DistinctionTM, which annually honor outstanding licensing and intellectual property-related agreements.
